의료 관련 주식
| # | 이전 7일 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3781 |  ARMP Armata Pharmaceuticals, Inc. Common Stock | 3.09 USD | +10.36% | -21.37% | -28.47% | -62.18% | 114.89 M USD | ||
| 3783 |  ENGN enGene Therapeutics Inc. - Common Stock | 1.71 USD | +9.62% | -2.84% | -10.00% | -79.64% | 114.60 M USD | ||
| 3789 |  ADAG Adagene Inc - ADS, each representing 1.25 | 2.40 USD | +4.80% | -13.04% | -27.49% | +30.43% | 113.73 M USD | ||
| 3792 |  CPIX Cumberland Pharmaceuticals Inc. - Common Stock | 7.54 USD | +0.67% | +9.59% | +6.20% | +118.55% | 112.97 M USD | ||
| 3793 |  SEER Seer, Inc. - Class A Common Stock | 2.04 USD | -1.92% | -5.56% | +6.81% | -6.42% | 112.96 M USD | ||
| 3796 |  FHTX Foghorn Therapeutics Inc. - Common Stock | 1.89 USD | +2.16% | -3.57% | -55.74% | -53.68% | 112.24 M USD | ||
| 3797 |  GNLX Genelux Corporation - Common Stock | 2.48 USD | +6.90% | 0.00% | +5.08% | -54.24% | 112.21 M USD | ||
| 3798 |  LENZ LENZ Therapeutics, Inc. - Common Stock | 3.57 USD | +4.08% | +1.13% | -15.60% | -89.02% | 112.17 M USD | ||
| 3808 |  TNXP Tonix Pharmaceuticals Holding Corp. - Common Stock | 6.42 USD | +0.31% | -11.69% | -46.50% | -57.23% | 110.11 M USD | ||
| 3811 |  VTVT vTv Therapeutics Inc. - Class A Common Stock | 27.59 USD | +0.25% | -8.52% | -10.68% | +34.59% | 109.09 M USD | ||
| 3814 |  APYX Apyx Medical Corporation - Common Stock | 2.56 USD | -0.39% | +7.56% | -15.79% | -16.34% | 107.84 M USD | ||
| 3816 |  INO Inovio Pharmaceuticals, Inc. - Common Stock | 1.04 USD | +5.05% | -5.45% | -9.57% | -57.38% | 107.53 M USD | ||
| 3817 |  DH Definitive Healthcare Corp. - Class A Common Stock | 1.00 USD | +1.01% | +3.09% | +3.09% | -65.52% | 106.74 M USD | ||
| 3820 |  STXS Stereotaxis, Inc. Common Stock | 1.06 USD | +1.92% | -3.64% | -22.06% | -49.04% | 106.21 M USD | ||
| 3824 |  LUCD Lucid Diagnostics Inc. - Common Stock | 0.52 USD | -3.70% | -20.00% | -36.59% | -57.02% | 105.69 M USD | ||
| 3831 |  IFRX InflaRx N.V. - Common Stock | 1.44 USD | -2.70% | -7.10% | -29.06% | +20.00% | 104.10 M USD | ||
| 3832 |  VANI Vivani Medical, Inc. - Common Stock | 1.15 USD | -0.86% | -5.74% | -5.74% | -23.33% | 103.73 M USD | ||
| 3834 |  AIRS AirSculpt Technologies, Inc. - Common Stock | 1.42 USD | 0.00% | -13.94% | -33.95% | -84.62% | 102.38 M USD | ||
| 3837 |  COYA Coya Therapeutics, Inc. - Common Stock | 4.34 USD | +3.83% | -13.20% | -4.41% | -30.89% | 101.81 M USD | ||
| 3842 |  IMDX Insight Molecular Diagnostics Inc. - Common Stock | 3.06 USD | +9.68% | -6.99% | -16.62% | -33.48% | 100.14 M USD |
뉴스 의료 관련 주식
매크로제닉스, 진행성 고형암 환자 대상 비공개 표적 항체-약물 접합체 MGC030의 1상 임상시험에서 첫 환자 투여
목요일 장중 변동한 12개 헬스케어 주식
다이애딕 인터내셔널 13G 공시: 엠퍼리 에셋 매니지먼트, 9월 30일 기준 8.35% 지분 보유 보고
뉴라시스, 의료 정책 적용 범위가 2,600만 명 이상의 의료 보험 가입자에게 확대되었다고 발표
에데사 바이오테크, 백반증 치료제 EB06의 2상 임상시험을 위한 신약 임상시험계획(IND) 신청에 대해 FDA 승인 획득
렉사리아 바이오사이언스, 디하이드라테크-CBD 조성물 및 디하이드라테크-세마글루타이드 모두 평가한 동물실험 GLP-1-A26-1 결과 발표···아쉽게도 뇌 조직 내 DHT-SEMA 농도는 본 연구에 사용된 생물학적 분석의 정량 하한선 이하 수준
웨드부시, 수트로 바이오파마에 대한 ‘시장수익률 상회’ 의견 재확인 및 목표주가 60달러 유지
Gainers 의료 관련 주식
 ESLA Estrella Immunopharma, Inc. - Common Stock | 0.54 | +68.75% |
 DRMA Dermata Therapeutics, Inc. - Common Stock | 0.91 | +37.88% |
 INDP Indaptus Therapeutics, Inc. - Common Stock | 2.85 | +28.96% |
 HUMA Humacyte, Inc. - Common Stock | 0.44 | +25.71% |
 NMRA Neumora Therapeutics, Inc. - Common Stock | 0.43 | +22.86% |
 PIIIW P3 Health Partners Inc. - Warrant | 0.0072 | +20.00% |
 TRIB Trinity Biotech plc - American Depositary Shares each represent | 7.93 | +19.97% |
 AKTX Akari Therapeutics Plc - American Depositary Shares | 8.67 | +19.75% |
Losers 의료 관련 주식
 SPRC SciSparc Ltd. - Ordinary Shares | 2.00 | -44.75% |
 CDIOW Cardio Diagnostics Holdings Inc. - Warrant | 0.0064 | -28.09% |
 NXGLW NexGel, Inc - Warrant | 0.0065 | -27.78% |
 DRTSW Alpha Tau Medical Ltd. - Warrant | 2.9900 | -17.40% |
 PFSA Profusa, Inc. - Common Stock | 1.07 | -16.41% |
 MDAIW Spectral AI, Inc. - Warrants | 0.4100 | -16.33% |
 CDTTW CDT Equity Inc. - Warrant | 0.0061 | -15.28% |
 PTN Palatin Technologies, Inc. Common Stock | 6.49 | -15.27% |